dr platzbecker on first-line atra/ato in high-risk acute promyelocytic leukemia
Published 2 months ago • 208 plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
1:43
first results of the apollo trial: atra-ato versus soc in high-risk acute promyelocytic leukemia
-
2:38
atra-ato regimen with idarubicin could become the new standard of care in high-risk acute promye...
-
2:29
dr. lo-coco on arsenic trioxide in acute promyelocytic leukemia
-
4:04
uwe platzbecker | what are the latest treatment management strategies for patients with apl?
-
3:52
timely diagnosis of acute promyelocytic leukemia
-
2:02
ash 2016: a new combo for low and intermediate risk apl patients: arsenic trioxide (ato) atra
-
1:04
dr. wetzler on arsenic trioxide in acute promyelocytic leukemia
-
2:19
dr. lo-coco on arsenic trioxide in acute promyelocytic leukemia
-
1:18
dr. waxman on advancements in apl
-
2:25
updates on chemotherapy-free treatment approaches for apl
-
2:50
chemo-free approach in acute promyelocytic leukemia (apl) treatment
-
1:49
the efficacy of ato and atra for apl
-
4:05
apollo: ato-atra versus standard atra chemotherapy for patients with newly diagnosed high-risk apl
-
0:52
acute promyelocytic leukemia (apl) survival rate - part 1 #apl #leukemia #cancercure #aml
-
1:57
long-term outcomes for patients with apl treated with atro-ato: a harmony alliance study
-
3:12
advances & unmet needs in apl
-
3:41
long-term follow-up: aml17 trial of ato and atra vs the standard of care in apl
-
3:41
advancements in apl treatment: oral ato, mrd and treatment objectives
-
0:48
acute promyelocytic leukemia (apl) survival rate - part 2 #apl #leukemia #cancercure #aml